Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Mol Cell ; 82(20): 3810-3825.e8, 2022 10 20.
Article in English | MEDLINE | ID: mdl-36108631

ABSTRACT

Human mixed-lineage leukemia (MLL) family methyltransferases methylate histone H3 lysine 4 to different methylation states (me1/me2/me3) with distinct functional outputs, but the mechanism underlying the different product specificities of MLL proteins remains unclear. Here, we develop methodologies to quantitatively measure the methylation rate difference between mono-, di-, and tri-methylation steps and demonstrate that MLL proteins possess distinct product specificities in the context of the minimum MLL-RBBP5-ASH2L complex. Comparative structural analyses of MLL complexes by X-ray crystal structures, fluorine-19 nuclear magnetic resonance, and molecular dynamics simulations reveal that the dynamics of two conserved tyrosine residues at the "F/Y (phenylalanine/tyrosine) switch" positions fine-tune the product specificity. The variation in the intramolecular interaction between SET-N and SET-C affects the F/Y switch dynamics, thus determining the product specificities of MLL proteins. These results indicate a modified F/Y switch rule applicable for most SET domain methyltransferases and implicate the functional divergence of MLL proteins.


Subject(s)
Histone-Lysine N-Methyltransferase , Leukemia , Humans , Histone-Lysine N-Methyltransferase/metabolism , Histones/metabolism , Methyltransferases/genetics , Methyltransferases/metabolism , Lysine/metabolism , Fluorine/metabolism , Myeloid-Lymphoid Leukemia Protein/metabolism , Tyrosine , Phenylalanine
SELECTION OF CITATIONS
SEARCH DETAIL